4//SEC Filing
Singhal Anil K. 4
Accession 0000950170-25-086168
CIK 0001785530other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:10 PM ET
Size
8.2 KB
Accession
0000950170-25-086168
Insider Transaction Report
Form 4
Singhal Anil K.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+8,358→ 8,358 totalExercise: $1.29Exp: 2035-06-11→ Common Stock (8,358 underlying) - Award
Stock Option (right to buy)
2025-06-11+9,000→ 9,000 totalExercise: $1.23Exp: 2035-06-10→ Common Stock (9,000 underlying)
Footnotes (3)
- [F1]Represents stock options that the Reporting Person was entitled to receive pursuant to the non-employee director compensation policy of Werewolf Therapeutics, Inc. (the "Company") in effect at the time of the Reporting Person's appointment to the board of directors of the Company, which were not previously granted due to a clerical error.
- [F2]The option was granted on June 11, 2025. One-third of the total number of shares underlying the option vest on February 19, 2026, and the remaining shares vest thereafter in equal monthly installments until February 19, 2028, subject to continued service by the Reporting Person as a director to the Company through each applicable vesting date.
- [F3]The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001982984
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:10 PM ET
- Size
- 8.2 KB